These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 35628517)
41. NF1 microduplications: identification of seven nonrelated individuals provides further characterization of the phenotype. Moles KJ; Gowans GC; Gedela S; Beversdorf D; Yu A; Seaver LH; Schultz RA; Rosenfeld JA; Torchia BS; Shaffer LG Genet Med; 2012 May; 14(5):508-14. PubMed ID: 22241097 [TBL] [Abstract][Full Text] [Related]
42. Screening 500 unselected neurofibromatosis 1 patients for deletions of the NF1 gene. Kluwe L; Siebert R; Gesk S; Friedrich RE; Tinschert S; Kehrer-Sawatzki H; Mautner VF Hum Mutat; 2004 Feb; 23(2):111-116. PubMed ID: 14722914 [TBL] [Abstract][Full Text] [Related]
43. Neurofibromatosis type 1 peripheral nerve tumors: aberrant activation of the Ras pathway. Feldkamp MM; Angelov L; Guha A Surg Neurol; 1999 Feb; 51(2):211-8. PubMed ID: 10029430 [TBL] [Abstract][Full Text] [Related]
44. Two NF1 mutations: frameshift in the GAP-related domain, and loss of two codons toward the 3' end of the gene. Abernathy CR; Colman SD; Kousseff BG; Wallace MR Hum Mutat; 1994; 3(4):347-52. PubMed ID: 8081387 [TBL] [Abstract][Full Text] [Related]
45. A novel neurofibromin (NF1) interaction with the leucine-rich pentatricopeptide repeat motif-containing protein links neurofibromatosis type 1 and the French Canadian variant of Leigh's syndrome in a common molecular complex. Arun V; Wiley JC; Kaur H; Kaplan DR; Guha A J Neurosci Res; 2013 Apr; 91(4):494-505. PubMed ID: 23361976 [TBL] [Abstract][Full Text] [Related]
46. Is osseous dysplasia a primary feature of neurofibromatosis 1 (NF1)? Alwan S; Tredwell SJ; Friedman JM Clin Genet; 2005 May; 67(5):378-90. PubMed ID: 15811002 [TBL] [Abstract][Full Text] [Related]
47. Independent NF1 and PTPN11 mutations in a family with neurofibromatosis-Noonan syndrome. Thiel C; Wilken M; Zenker M; Sticht H; Fahsold R; Gusek-Schneider GC; Rauch A Am J Med Genet A; 2009 Jun; 149A(6):1263-7. PubMed ID: 19449407 [TBL] [Abstract][Full Text] [Related]
48. Pathogenic Mutations Associated with Legius Syndrome Modify the Spred1 Surface and Are Involved in Direct Binding to the Ras Inactivator Neurofibromin. Führer S; Tollinger M; Dunzendorfer-Matt T J Mol Biol; 2019 Sep; 431(19):3889-3899. PubMed ID: 31401120 [TBL] [Abstract][Full Text] [Related]
50. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications. Gottfried ON; Viskochil DH; Couldwell WT Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723 [TBL] [Abstract][Full Text] [Related]
51. Phenotypic and genetic characterization of novel variant in the NF1 gene underlying neurofibromatosis type 1 in five Chinese families. Habulieti X; Sun L; Liu J; Guo K; Yang X; Wang R; Ma D; Zhang X Sci China Life Sci; 2021 Dec; 64(12):2206-2209. PubMed ID: 33999308 [No Abstract] [Full Text] [Related]
52. [Analysis of NF1 gene mutations among eleven sporadic patients with neurofibromatosis type 1]. Peng C; Ma S; Tang X; Yang J Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Aug; 35(4):480-483. PubMed ID: 30098238 [TBL] [Abstract][Full Text] [Related]
53. Somatic mutations in the neurofibromatosis 1 gene in human tumors. Li Y; Bollag G; Clark R; Stevens J; Conroy L; Fults D; Ward K; Friedman E; Samowitz W; Robertson M Cell; 1992 Apr; 69(2):275-81. PubMed ID: 1568247 [TBL] [Abstract][Full Text] [Related]
55. Valosin-containing protein and neurofibromin interact to regulate dendritic spine density. Wang HF; Shih YT; Chen CY; Chao HW; Lee MJ; Hsueh YP J Clin Invest; 2011 Dec; 121(12):4820-37. PubMed ID: 22105171 [TBL] [Abstract][Full Text] [Related]
56. Emerging therapeutic targets for neurofibromatosis type 1. Walker JA; Upadhyaya M Expert Opin Ther Targets; 2018 May; 22(5):419-437. PubMed ID: 29667529 [TBL] [Abstract][Full Text] [Related]
57. Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients. Ars E; Kruyer H; Morell M; Pros E; Serra E; Ravella A; Estivill X; Lázaro C J Med Genet; 2003 Jun; 40(6):e82. PubMed ID: 12807981 [No Abstract] [Full Text] [Related]
58. [Analysis of NF1 gene variant in a sporadic case with neurofibromatosis type 1]. Zhao X; Cai L; Zhang L; Wang P; Zhang G Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Aug; 37(8):871-874. PubMed ID: 32761598 [TBL] [Abstract][Full Text] [Related]
59. Pulmonary hypertension in patients with neurofibromatosis type I. Montani D; Coulet F; Girerd B; Eyries M; Bergot E; Mal H; Biondi G; Dromer C; Hugues T; Marquette C; O'Connell C; O'Callaghan DS; Savale L; Jaïs X; Dorfmüller P; Begueret H; Bertoletti L; Sitbon O; Bellanné-Chantelot C; Zalcman G; Simonneau G; Humbert M; Soubrier F Medicine (Baltimore); 2011 May; 90(3):201-211. PubMed ID: 21512413 [TBL] [Abstract][Full Text] [Related]
60. Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors. Dasgupta B; Yi Y; Chen DY; Weber JD; Gutmann DH Cancer Res; 2005 Apr; 65(7):2755-60. PubMed ID: 15805275 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]